IRIS UniCatt

Macchia, Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.077
EU - Europa 7.925
AS - Asia 7.415
SA - Sud America 1.277
AF - Africa 234
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 15
Totale 25.958
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.813
SG - Singapore 3.467
DE - Germania 2.961
CN - Cina 1.671
SE - Svezia 1.364
BR - Brasile 1.061
VN - Vietnam 718
IT - Italia 705
FR - Francia 651
UA - Ucraina 566
GB - Regno Unito 375
IN - India 367
IE - Irlanda 326
FI - Finlandia 271
ID - Indonesia 213
JP - Giappone 198
PL - Polonia 192
CA - Canada 154
HK - Hong Kong 147
TR - Turchia 134
RU - Federazione Russa 128
BD - Bangladesh 93
AR - Argentina 77
IQ - Iraq 74
NL - Olanda 71
MX - Messico 57
BE - Belgio 54
CI - Costa d'Avorio 54
ZA - Sudafrica 50
CZ - Repubblica Ceca 44
AT - Austria 43
ES - Italia 40
SA - Arabia Saudita 35
EC - Ecuador 33
IR - Iran 33
LT - Lituania 29
PK - Pakistan 29
KR - Corea 28
CO - Colombia 27
EG - Egitto 27
MA - Marocco 27
KE - Kenya 25
UZ - Uzbekistan 23
AE - Emirati Arabi Uniti 22
PH - Filippine 22
VE - Venezuela 20
JO - Giordania 19
CL - Cile 17
JM - Giamaica 15
TN - Tunisia 15
NP - Nepal 13
PY - Paraguay 13
UY - Uruguay 12
EU - Europa 11
IL - Israele 11
RO - Romania 11
AU - Australia 10
CH - Svizzera 10
AL - Albania 9
AZ - Azerbaigian 9
BH - Bahrain 9
DZ - Algeria 9
HU - Ungheria 9
MY - Malesia 9
BG - Bulgaria 8
GR - Grecia 8
OM - Oman 8
PE - Perù 8
PT - Portogallo 8
RS - Serbia 8
SN - Senegal 8
BO - Bolivia 7
DO - Repubblica Dominicana 7
KG - Kirghizistan 7
PS - Palestinian Territory 7
AM - Armenia 6
ET - Etiopia 6
LK - Sri Lanka 6
SY - Repubblica araba siriana 6
CR - Costa Rica 5
DK - Danimarca 5
KZ - Kazakistan 5
LB - Libano 5
LU - Lussemburgo 5
NZ - Nuova Zelanda 5
MT - Malta 4
NI - Nicaragua 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
HN - Honduras 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
NO - Norvegia 3
AO - Angola 2
BS - Bahamas 2
EE - Estonia 2
GY - Guiana 2
Totale 25.915
Salva come PNG Salva come JPEG
Città #
Singapore 1.911
Chandler 1.363
Ashburn 900
San Jose 850
Beijing 364
Dublin 323
Jacksonville 321
The Dalles 264
San Mateo 260
Ho Chi Minh City 240
Los Angeles 228
New York 219
Lauterbourg 216
Nanjing 201
Jakarta 194
Wilmington 181
Hanoi 176
Warsaw 169
Dearborn 165
Tokyo 162
Munich 159
Milan 149
Boston 143
Nürnberg 140
Hefei 132
Frankfurt am Main 130
Hong Kong 124
Bremen 123
Dallas 118
Rome 117
Woodbridge 116
Marseille 112
Helsinki 109
Hyderabad 107
Ann Arbor 106
São Paulo 105
Houston 89
Izmir 88
Lawrence 85
Cattolica 84
Princeton 79
Moscow 78
Fairfield 76
Nanchang 76
Seattle 62
St Louis 62
Santa Clara 61
Council Bluffs 57
Redwood City 56
Abidjan 54
Brussels 53
Orem 51
Buffalo 49
Chicago 47
Toronto 47
London 42
Leawood 40
Shanghai 40
Zhengzhou 37
Düsseldorf 36
Guangzhou 36
University Park 36
Da Nang 35
Turku 35
Kent 34
Paris 34
Shenyang 34
Montreal 33
Stockholm 33
Amsterdam 32
Hebei 32
Kunming 32
Phoenixville 32
Augusta 31
Tianjin 31
Brooklyn 29
Changsha 29
Fremont 29
Lancaster 29
Nuremberg 29
Boardman 28
Johannesburg 28
Lappeenranta 28
Pune 27
Cambridge 26
Jiaxing 26
Rio de Janeiro 26
Atlanta 25
Falls Church 25
Mountain View 25
Seoul 25
Baghdad 24
Haiphong 24
Mumbai 24
Denver 23
Nairobi 23
Norwalk 23
Phoenix 23
Vienna 23
Detroit 22
Totale 13.289
Salva come PNG Salva come JPEG
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 862
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 296
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 228
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 226
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 224
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 216
Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report 215
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 210
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 200
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 191
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 191
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 188
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 187
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 187
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 187
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 186
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 185
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 185
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 185
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 184
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 182
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 182
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 181
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 180
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 178
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 174
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 174
In Vivo Portal Dosimetry by an Ionization Chamber 173
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 173
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 173
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 173
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 173
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 170
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 168
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 167
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 167
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 167
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 167
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 167
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 164
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 164
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 164
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 163
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 163
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 162
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 160
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 159
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 157
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 157
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 157
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 156
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 156
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 155
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 155
An in-vivo dosimetry procedure for Elekta step and shoot IMRT 153
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 151
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 150
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 150
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 150
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 149
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 149
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 148
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 147
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 147
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance 146
Real time transit dosimetry for the breath-hold radiotherapy technique experience 145
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 144
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 144
CT angiography-based radiomics as a tool for carotid plaque characterization: a pilot study 140
Successful Treatment of a Young Patient with Locally Advanced Clear Cell Adenocarcinoma of the Uterine Cervix Undergoing Chemoradiation Followed by Radical Surgery 140
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: Impact on outcome and treatment-related complications. 139
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 139
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 139
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 138
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 138
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 138
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 137
Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups 137
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 136
Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients (Journal of Cancer Research and Clinical Oncology, (2021), 147, 3, (661-667), 10.1007/s00432-020-03411-7) 135
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 134
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 133
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 133
Multidisciplinary Tumor Board Smart Virtual Assistant in Locally Advanced Cervical Cancer: A Proof of Concept 133
Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery 132
Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy 132
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 131
Linac-based extracranial radiosurgery with Elekta volumetric modulated arc therapy and an anatomy-based treatment planning system: Feasibility and initial experience 130
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 130
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 129
Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study 129
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 128
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 128
Personalized Automation of Treatment Planning for Linac-Based Stereotactic Body Radiotherapy of Spine Cancer 127
Radiotherapy of prostate carcinoma: A comparison of the predictive role of EAU versus NCCN risk stratification systems 127
Optimal beam margins in linac-based VMAT stereotactic ablative body radiotherapy: A Pareto front analysis for liver metastases 125
Intraluminal Brachytherapy in Unresectable Extrahepatic Biliary Duct Cancer: An Italian Pooled Analysis 124
Synchronous male carcinoma of the breast, exocrine pancreas, and prostate 123
Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer 123
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 122
Totale 16.716
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.354
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.354
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021352 0 0 0 0 0 0 0 0 0 98 197 57
2021/20221.580 153 107 15 107 111 57 23 216 62 111 308 310
2022/20233.828 521 539 262 610 263 423 223 292 419 79 148 49
2023/20241.701 66 484 75 129 52 215 101 131 20 52 237 139
2024/20253.772 106 84 240 136 419 103 97 175 600 446 729 637
2025/20269.250 1.417 296 552 962 1.702 580 1.715 619 766 641 0 0
Totale 26.753